1. KoffronA, HummelM, PattersonB, YanS, KaufmanD, et al. (1998) Cellular Localization of Latent Murine Cytomegalovirus. J Virol 72: 95–103.
2. JarvisMA, NelsonJA (2002) Human cytomegalovirus persistence and latency in endothelial cells and macrophages. Curr Opin Microbiol 5: 403–407.
3. JarvisMA, NelsonJA (2007) Human cytomegalovirus tropism for endothelial cells: not all endothelial cells are created equal. J Virol 81: 2095–2101.
4. MercerJ, WileyC, SpectorD (1988) Pathogenesis of Murine Cytomegalovirus Infection: Identification of Infected Cells in the Spleen during Acute and Latent Infections. J Virol 62: 987–997.
5. PomeroyC, HillerenP, JordanM (1991) Latent Murine Cytomegalovirus DNA in Splenic Stromal Cells of Mice. J Virol 65: 3330–3334.
6. HendrixM, SalimansM, van BovenC, BruggemanC (1990) High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 136: 23–28.
7. HendrixM, DormansP, KitslaarP, BosmanF, BruggemanC (1989) The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients. Am J Pathol 134: 1151–1157.
8. HendrixR, WagenaarM, SlobbeR, BruggemanC (1997) Widespread presence of cytomegalovirus DNA in tissues of healthy trauma victims. J Clin Pathol 50: 59–63.
9. Kondo K, Mocarski ES (1995) Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors. Scand J Infect Dis Suppl 99: 63–67.
10. ReevesM, SissonsP, SinclairJ (2005) Reactivation of human cytomegalovirus in dendritic cells. Discov Med 5: 170–174.
11. KondoK, KaneshimaH, MocarskiE (1994) Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc Natl Acad Sci U S A 91: 11879–11883.
12. KondoK, XuJ, MocarskiE (1996) Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc Natl Acad Sci U S A 93: 11137–11142.
13. GoodrumF, ReevesM, SinclairJ, HighK, ShenkT (2007) Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. Blood 110: 937–945.
14. GoodrumFD, JordanCT, HighK, ShenkT (2002) Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency. Proc Natl Acad Sci U S A 99: 16255–16260.
15. Taylor-WiedemanJ, SissonsJ, BorysiewiczL, SinclairJ (1991) Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 72: 2059–2064.
16. Söderberg-NauclérC, FishK, NelsonJ (1997) Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91: 119–126.
17. PollockJ, PrestiR, PaetzoldS, VirginH (1997) Latent murine cytomegalovirus infection in macrophages. Virology 227: 168–179.
18. GrzimekNK, DreisD, SchmalzS, ReddehaseMJ (2001) Random, asynchronous, and asymmetric transcriptional activity of enhancer-flanking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs. J Virol 75: 2692–2705.
19. KurzSK, ReddehaseMJ (1999) Patchwork pattern of transcriptional reactivation in the lungs indicates sequential checkpoints in the transition from murine cytomegalovirus latency to recurrence. J Virol 73: 8612–8622.
20. PolicB, HengelH, KrmpoticA, TrgovcichJ, PaviI, et al. (1998) Hierarchical and Redundant Lymphocyte Subset Control Precludes Cytomegalovirus Replication during Latent Infection. J Exp Med 188: 1047–1054.
21. CroughT, KhannaR (2009) Immunobiology of Human Cytomegalovirus: from Bench to Bedside. Clin Microbal Rev 22: 76–98.
22. SimonCO, HoltappelsR, TervoHM, BohmV, DaubnerT, et al. (2006) CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation. J Virol 80: 10436–10456.
23. HoltappelsR, BohmV, PodlechJ, ReddehaseMJ (2008) CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model. Med Microbiol Immunol 197: 125–134.
24. WalterE, GreenbergP, GilbertM, FinchR, WatanabeK, et al. (1995) Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 333: 1038–1044.
25. ReddehaseM, JonjićS, WeilandF, MutterW, KoszinowskiU (1988) Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors. J Virol 62: 1061–1065.
26. RiddellS, WatanabeK, GoodrichJ, LiC, AghaM, et al. (1992) Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257: 238–241.
27. KarrerU, SierroS, WagnerM, OxeniusA, HengelH, et al. (2003) Memory Inflation: Continuous Accumulation of Antiviral CD8+ T Cells Over Time. J Immunol 170: 2022–2029.
28. MunksMW, ChoKS, PintoAK, SierroS, KlenermanP, et al. (2006) Four Distinct Patterns of Memory CD8 T Cell Responses to Chronic Murine Cytomegalovirus Infection. J Immunol 177: 450–458.
29. HoltappelsR, Pahl-SeibertM-F, ThomasD, ReddehaseMJ (2000) Enrichment of Immediate-Early 1 (m123/pp89) Peptide-Specific CD8 T Cells in a Pulmonary CD62Llo Memory-Effector Cell Pool during Latent Murine Cytomegalovirus Infection of the Lungs. J Virol 74: 11495–11503.
30. KomatsuH, SierroS, V. CueroA, KlenermanP (2003) Population analysis of antiviral T cell responses using MHC class I-peptide tetramers. Clin Exp Immunol 134: 9–12.
31. HoltappelsR, ThomasD, PodlechJ, ReddehaseMJ (2002) Two Antigenic Peptides from Genes m123 and m164 of Murine Cytomegalovirus Quantitatively Dominate CD8 T-Cell Memory in the H-2d Haplotype. Journal of Virology 76: 151–164.
32. SylwesterAW, MitchellBL, EdgarJB, TaorminaC, PelteC, et al. (2005) Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 202: 673–685.
33. BolingerB, SimsS, O'HaraG, de LaraC, TchilianE, et al. (2013) A new model for CD8+ T cell memory inflation based upon a recombinant adenoviral vector. J Immunol 190: 4162–4174.
34. LangA, BrienJD, Nikolich-ZugichJ (2009) Inflation and long-term maintenance of CD8 T cells responding to a latent herpesvirus depend upon establishment of latency and presence of viral antigens. J Immunol 183: 8077–8087.
35. NorbeckO, IsaA, PohlmannC, BrolidenK, KasprowiczV, et al. (2005) Sustained CD8+ T-cell responses induced after acute parvovirus B19 infection in humans. J Virol 79: 12117–12121.
36. SimmonsR, SharpC, LevineJ, BownessP, SimmondsP, et al. (2013) Evolution of CD8+ T cell responses after acute PARV4 infection. J Virol 87: 3087–3096.
37. SimmonsR, SharpC, SimsS, KloverprisH, GoulderP, et al. (2011) High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo. J Infect Dis 203: 1378–1387.
38. SwansonPA, PackCD, HadleyA, WangCR, StroynowskiI, et al. (2008) An MHC class Ib-restricted CD8 T cell response confers antiviral immunity. J Exp Med 205: 1647–1657.
39. IsaA, KasprowiczV, NorbeckO, LoughryA, JefferyK, et al. (2005) Prolonged activation of virus-specific CD8+T cells after acute B19 infection. PLoS Med 2: e343.
40. KaechSM, TanJT, WherryEJ, KoniecznyBT, SurhCD, et al. (2003) Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 4: 1191–1198.
41. SarkarS, KaliaV, HainingWN, KoniecznyBT, SubramaniamS, et al. (2008) Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J Exp Med 205: 625–640.
42. SierroS, RothkopfR, KlenermanP (2005) Evolution of diverse antiviral CD8+ T cell populations after murine cytomegalovirus infection. Eur J Immunol 35: 1113–1123.
43. SnyderCM, ChoKS, BonnettEL, van DommelenS, ShellamGR, et al. (2008) Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells. Immunity 29: 650–659.
44. MasopustD, HaS, VezysV, AhmedR (2006) Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination. J Immunol 177: 831–839.
45. WirthTC, XueHH, RaiD, SabelJT, BairT, et al. (2010) Repetitive antigen stimulation induces stepwise transcriptome diversification but preserves a core signature of memory CD8(+) T cell differentiation. Immunity 33: 128–140.
46. KrmpoticA, BubicI, PolicB, LucinP, JonjicS (2003) Pathogenesis of murine cytomegalovirus infection. Microb Infect 5: 1263–1277.
47. HansenSG, FordJC, LewisMS, VenturaAB, HughesCM, et al. (2011) Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 473: 523–527.
48. XuG, SmithT, GreyF, HillAB (2013) Cytomegalovirus-based cancer vaccines expressing TRP2 induce rejection of melanoma in mice. Biochem Biophys Res Commun 437: 287–291.
49. KlyushnenkovaEN, KouiavskaiaDV, ParkinsCJ, CaposioP, BottoS, et al. (2012) A cytomegalovirus-based vaccine expressing a single tumor-specific CD8+ T-cell epitope delays tumor growth in a murine model of prostate cancer. J Immunother 35: 390–399.
50. SnyderCM, ChoKS, BonnettEL, AllanJE, HillAB (2011) Sustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus. PLoS Pathog 7: e1002295.
51. van LeeuwenEM, de BreeGJ, RemmerswaalEB, YongSL, TesselaarK, et al. (2005) IL-7 receptor alpha chain expression distinguishes functional subsets of virus-specific human CD8+ T cells. Blood 106: 2091–2098.
52. TortiN, WaltonSM, BrockerT, RulickeT, OxeniusA (2011) Non-hematopoietic cells in lymph nodes drive memory CD8 T cell inflation during murine cytomegalovirus infection. PLoS Pathog 7: e1002313.
53. WallaceDL, MastersJE, De LaraCM, HensonSM, WorthA, et al. (2011) Human cytomegalovirus-specific CD8(+) T-cell expansions contain long-lived cells that retain functional capacity in both young and elderly subjects. Immunology 132: 27–38.
54. SeckertCK, SchaderSI, EbertS, ThomasD, FreitagK, et al. (2011) Antigen-presenting cells of haematopoietic origin prime cytomegalovirus-specific CD8 T-cells but are not sufficient for driving memory inflation during viral latency. J Gen Virol 92: 1994–2005.
55. ThomasAC, ForsterMR, BickerstaffAA, ZimmermanPD, WingBA, et al. (2010) Occult cytomegalovirus in vivarium-housed mice may influence transplant allograft acceptance. Transpl Immunol 23: 86–91.
56. TurulaH, SmithCJ, GreyF, ZurbachKA, SnyderCM (2013) Competition between T cells maintains clonal dominance during memory inflation induced by MCMV. Eur J Immunol 43: 1252–1263.
57. HsuKM, PrattJR, AkersWJ, AchilefuSI, YokoyamaWM (2009) Murine cytomegalovirus displays selective infection of cells within hours after systemic administration. J Gen Virol 90: 33–43.
58. SeckertCK, RenzahoA, TervoHM, KrauseC, DeegenP, et al. (2009) Liver sinusoidal endothelial cells are a site of murine cytomegalovirus latency and reactivation. J Virol 83: 8869–8884.
59. PinschewerD, OchsenbeinA, OdermattB, BrinkmannV, HengartnerH, et al. (2000) FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory. J Immunol 164: 5761–5770.
60. LedgerwoodLG, LalG, ZhangN, GarinA, EssesSJ, et al. (2008) The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Nat Immunol 9: 42–53.
61. BrinkmanCC, RouhaniSJ, SrinivasanN, EngelhardVH (2013) Peripheral tissue homing receptors enable T cell entry into lymph nodes and affect the anatomical distribution of memory cells. J Immunol 191: 2412–2425.
62. AndersonKG, SungH, SkonCN, LefrancoisL, DeisingerA, et al. (2012) Cutting edge: intravascular staining redefines lung CD8 T cell responses. J Immunol 189: 2702–2706.
63. GalkinaE, ThatteJ, DabakV, WilliamsMB, LeyK, et al. (2005) Preferential migration of effector CD8+ T cells into the interstitium of the normal lung. J Clin Invest 115: 3473–3483.
64. AndersonKG, Mayer-BarberK, SungH, BeuraL, JamesBR, et al. (2014) Intravascular staining for discrimination of vascular and tissue leukocytes. Nat Protoc 9: 209–222.
65. HertoghsK, MoerlandP, van StijnA, RemmerswaalE, YongS, et al. (2010) Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation. J Clin Invest 120: 4077–4090.
66. PodlechJ, HoltappelsR, Pahl-SeibertM-F, SteffensH-P, ReddehaseMJ (2000) Murine Model of Interstitial Cytomegalovirus Pneumonia in Syngeneic Bone Marrow Transplantation: Persistence of Protective Pulmonary CD8-T-Cell Infiltrates after Clearance of Acute Infection. J Virol 74: 7496–7507.
67. KurzSK, RappM, SteffensH-P, GrzimekNKA, SchmalzS, et al. (1999) Focal Transcriptional Activity of Murine Cytomegalovirus during Latency in the Lungs. J Virol 73: 482–494.
68. MatloubianM, LoC, CinamonG, LesneskiM, XuY, et al. (2004) Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427: 355–360.
69. ArnonTI, CysterJG (2014) Blood, sphingosine-1-phosphate and lymphocyte migration dynamics in the spleen. Curr Top Microbiol Immunol 378: 107–128.
70. Oliver P, Heike H, Stefanie W, Tim W, Angela S, et al.. (2006) Enhanced FTY720-Mediated Lymphocyte Homing Requires Gαi Signaling and Depends on β2 and β7 Integrin. J Immunol: 1474–1480.
71. FarringtonLA, SmithTA, GreyF, HillAB, SnyderCM (2013) Competition for antigen at the level of the APC is a major determinant of immunodominance during memory inflation in murine cytomegalovirus infection. J Immunol 190: 3410–3416.
72. KernM, PopovA, ScholzK, SchumakB, DjandjiD, et al. (2010) Virally infected mouse liver endothelial cells trigger CD8+ T-cell immunity. Gastroenterology 138: 336–346.
73. WarrenA, Le CouteurDG, FraserR, BowenDG, McCaughanGW, et al. (2006) T lymphocytes interact with hepatocytes through fenestrations in murine liver sinusoidal endothelial cells. Hepatology 44: 1182–1190.
74. HummelM, ZhangZ, YanS, DePlaenI, GoliaP, et al. (2001) Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency. J Virol 75: 4814–4822.
75. van de BergPJ, YongSL, RemmerswaalEB, van LierRA, ten BergeIJ (2012) Cytomegalovirus-induced effector T cells cause endothelial cell damage. Clin Vaccine Immunol 19: 772–779.
76. LangA, Nikolich-ZugichJ (2011) Functional CD8 T cell memory responding to persistent latent infection is maintained for life. J Immunol 187: 3759–3768.
77. HutchinsonS, SimsS, O'HaraG, SilkJ, GileadiU, et al. (2011) A dominant role for the immunoproteasome in CD8+ T cell responses to murine cytomegalovirus. PLoS One 6: e14646.
78. HoltappelsR, PodlechJ, Pahl-SeibertMF, JulchM, ThomasD, et al. (2004) Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues. J Exp Med 199: 131–136.
79. JungYW, RutishauserRL, JoshiNS, HabermanAM, KaechSM (2010) Differential localization of effector and memory CD8 T cell subsets in lymphoid organs during acute viral infection. J Immunol 185: 5315–5325.
80. RemmerswaalEB, HavenithSH, IduMM, van LeeuwenEM, van DonselaarKA, et al. (2012) Human virus-specific effector-type T cells accumulate in blood but not in lymph nodes. Blood 119: 1702–1712.
81. ZurbachKA, MoghbeliT, SnyderCM (2014) Resolving the titer of murine cytomegalovirus by plaque assay using the M2-10B4 cell line and low viscosity overlay. Virology Journal 11: 71.
82. ZhangJ, DongZ, ZhouR, LuoD, WeiH, et al. (2005) Isolation of Lymphocytes and Their Innate Immune Characterizations from Liver, Intestine, Lung and Uterus. Cell Mol Immunol 2: 271–280.
83. MegaJ, McGheeJ, KiyonoH (1992) Cytokine- and Ig-producing T cells in mucosal effector tissues: analysis of IL-5- and IFN-gamma-producing T cells, T cell receptor expression, and IgA plasma cells from mouse salivary gland-associated tissues. J Immunol 148: 2030–2038.